Evaluation of Topical Mitomycin C as Adjuvant Drug to Esophageal Dilation

Status Recruiting

Clinical Trial Summary

This study aims to evaluate mitomycin C as an adjunct to endoscopic treatment of esophageal strictures.

This is a crossover, controlled, clinical trial in which children with esophageal stricture will be randomized in two groups to receive either topical mitomycin or no additional treatment during standard esophageal dilation session.

Clinical Trial Description

Topical mitomycin C has been used as an adjunct drug to endoscopic treatment of aero-digestive strictures. There has been some case reports and case series of this application in esophageal strictures in children, with good results. Nevertheless, it lacks a controlled clinical trial to access the efficacy of the mitomycin C in this context.

This study aims to evaluate mitomycin C as an adjunct to endoscopic treatment of esophageal strictures.

This is a crossover placebo-controlled single-blind clinical trial.

Patients: Subjects up to 18 year-old, with esophageal stricture requiring endoscopic dilation, either due to dysphagia or by stricture preventing passage of the endoscope.

Inclusion criteria:

- peptic esophageal stricture

- post-surgical esophageal stricture

- caustic esophageal stricture

The patient will be randomized by one treatment group, either A or B.

- A. during the first endoscopic procedure it will be applied of topical mitomycin C over the esophageal mucosa after dilation, then the second procedure (in two weeks) will be performed as a standard dilation, without mitomycin C.

- B. the first procedure will be performed in a standard way, and after two weeks, in the second procedure mytomicin-C will be spread over the esophageal mucosa.

The allocation will not be informed to the patient. At the end of the study protocol, the patients will be clinically evaluated and the dilation program will continue on discretion of the assistant doctor. The target esophageal bore is 11 mm (or 12.8 mm if age above 5 yrs).

Mitomycin C will be applied over the esophageal mucosa in the site of stricture after dilation with a cotton pledget soaked in solution (0.4mg/ml) by three minutes. The pledget will he held over the mucosa with a biopsy forceps.

Clinical evaluation. Dysphagia will be evaluated by a structured questionnaire, using a Likert scale. The patient will answer the questionnaire daily.

Main outcome measure: Number of days with improved symptom (dysphagia) after a session. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00551824
Study type	Interventional
Source	Federal University of São Paulo
Contact	Rodrigo S Machado, PhD
Phone	55-11-5576-4344
Email	rodrigo@gastroped.epm.br
Status	Recruiting
Phase	N/A
Start date	October 2007
Completion date	March 2009

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04372784` - Cryoablation for Benign Gastrointestinal Anastomotic Strictures	N/A
Recruiting	`NCT05581173` - Self-Assembling Matrix Forming Gel to Prevent Stricture Formation
Recruiting	`NCT04406428` - NKI Therapy Compared to Usual Care of Recurrent Esophagogastric Anastomotic Strictures	N/A
Completed	`NCT04284826` - Mitomycin-C Injection Therapy in Refractory Esophageal Stricture	N/A
Terminated	`NCT03898661` - Collagenase Clostridium Histolyticum for Refractory Iatrogenic Esophageal Strictures	Early Phase 1
Withdrawn	`NCT04730076` - Balloon Dilation Methods for Benign Esophageal Stricture	N/A
Active, not recruiting	`NCT03885310` - INGEST I Pilot Study	N/A
Completed	`NCT02069847` - Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy	Phase 2
Completed	`NCT03039608` - Effect of a Combination of Local Steroid Injection With Oral Steroid Administration for the Prevention on Esophageal Stricture After Endoscopic Submucosal Dissection for Early Esophageal Neoplasm	N/A
Terminated	`NCT02354716` - EndoFLIP Use in Upper GI Tract Stenosis
Recruiting	`NCT05561114` - Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus	Phase 3
Not yet recruiting	`NCT04524897` - The Use of Triamcinolone Injection in Treatment of Refractory Benign Esophageal Stricture in Children	Phase 4
Not yet recruiting	`NCT04221867` - Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Esophageal Strictures (ESOGRAFT)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation of Topical Mitomycin C as Adjuvant Drug to Esophageal Dilation in Children

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms